GVK Biosciences

Hyderabad, India

GVK Biosciences

Hyderabad, India
SEARCH FILTERS
Time filter
Source Type

Drug Discovery Informatics Market is accounted for $1.91 billion in 2015 and is expected to reach $6.94 billion by 2022 growing at a CAGR of 17.5% from 2015 to 2022Pune , India - April 25, 2017 /MarketersMedia/ — Drug Discovery Informatics Industry Description Global Drug Discovery Informatics Market is accounted for $1.91 billion in 2015 and is expected to reach $6.94 billion by 2022 growing at a CAGR of 17.5% from 2015 to 2022. The rising demand for computational technology is the primary factor favouring the market growth. Furthermore, Drug discovery industry and rising number of technologically advanced products are the key drivers for the Drug Discovery Informatics market. However, Lack of information technology and critical attributes of data evaluation are limiting the market growth. The recent trends in Drug Discovery Informatics are considerable shift observed from traditional in-vitro drug development to computer aided drug designing, as costly failures of late drug development increases the use of in-silico models for early ADME/Toxicity screening. Sequence analysis platforms services accounted the largest revenue share and are expected to continue and dominate the market over the forecast period. North America commanded the largest share driven by the increasing demand for computational technology. However, Asia Pacific is projected to register the fastest growth over the forecast period owing to technological developments in the software and drug nano technology fields carried out in the developing economies. Request for Sample Report @ https://www.wiseguyreports.com/sample-request/456587-drug-discovery-informatics-global-market-outlook-2015 Some of the key players in the market include ChemAxon, GVK Biosciences, Jubilant Biosys, Selvita, Certara, Infosys, Albany Molecular Research Inc., BoehringerIngelheim GmBh,, DiscoverX, Charles River Laboratories, Covance, Collaborative Drug Discovery Inc., Novo Informatics, UCB and Evotec. Modes Covered: • In-house Informatics • Outsourced Informatics Services Covered: • Molecular Modelling • Sequence Analysis Platforms • Docking • Clinical Trial Data Management • Other Services Leave a Query @ https://www.wiseguyreports.com/enquiry/456587-drug-discovery-informatics-global-market-outlook-2015 Regions Covered: • North America o US o Canada o Mexico • Europe o Germany o France o Italy o UK o Spain o Rest of Europe • Asia Pacific o Japan o China o India o Australia o New Zealand o Rest of Asia Pacific • Rest of the World o Middle East o Brazil o Argentina o South Africa o Egypt What our report offers: - Market share assessments for the regional and country level segments - Market share analysis of the top industry players - Strategic recommendations for the new entrants - Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) - Strategic recommendations in key business segments based on the market estimations - Competitive landscaping mapping the key common trends - Company profiling with detailed strategies, financials, and recent developments - Supply chain trends mapping the latest technological advancements Buy now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=456587 Continued... Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (US) Ph: +44 208 133 9349 (UK) Contact Info:Name: NORAH TRENTEmail: sales@wiseguyreports.comOrganization: WISE GUY RESEARCH CONSULTANTS PVT LTDAddress: Office No. 528, Amanora Chambers Magarpatta Road, Hadapsar Pune - 411028Phone: +91 841 198 5042Source URL: http://marketersmedia.com/drug-discovery-informatics-market-2017-global-analysis-opportunities-and-forecast-to-2022/190033For more information, please visit https://www.wiseguyreports.com/sample-request/456587-drug-discovery-informatics-global-market-outlook-2015Source: MarketersMediaRelease ID: 190033


News Article | December 2, 2016
Site: www.businesswire.com

HYDERABAD, Indien--(BUSINESS WIRE)--GVK Biosciences, einer der führenden Life-Science-Dienstleister Asiens, hat heute die Inbetriebnahme eines Service-Labors für Analytik im indischen Hyderabad bekannt gegeben. Die GMP-konforme Einrichtung wird von einem validierten Laborinformationsmanagementsystem (LIMS) unterstützt. Sie entspricht den höchsten Qualitätsstandards, die von Regulierungsbehörden und Kunden bei der Entwicklung medizinischer Produkte und deren Vertrieb gefordert werden. GVK BIO ka


Rehan H.S.,Lady Hardinge Medical College | Chopra D.,Lady Hardinge Medical College | Sah R.K.,Lady Hardinge Medical College | Chawla T.,Lady Hardinge Medical College | And 2 more authors.
Journal of Infection and Public Health | Year: 2012

Background: Unsafe injection practices are prevalent worldwide and may result in spread of infection. Thus the present study was planned to observe the injection practices of healthcare professionals (HCP), including aseptic precautions and disposal of used syringes/needle. Materials and methods: Injection practices were observed in the outpatients and inpatients departments. Questionnaire was designed, tested and administered for this purpose. Results: 130 patients receiving injections were observed. Overall injection practices of the HCP were satisfactory. However, unsafe practices with respect to not washing hands (95.4%), not wearing/changing gloves (61.6%), recapping of needles (12.2%), wiping of needle with swab (15.4%) and breaking of ampoule with solid object (44.4%) were observed. Conclusion: The problem of unsafe injections can be successfully addressed by organizing continuing medical education/symposium/workshops for improving the knowledge, attitude and practices of the HCP. Periodic monitoring and such interventions may also further improve safe injection practices. © 2012 King Saud Bin Abdulaziz University for Health Sciences.


News Article | December 2, 2016
Site: www.businesswire.com

HYDERABAD, Inde--(BUSINESS WIRE)--GVK Biosciences, l’une des principales organisations de services en sciences de la vie d’Asie, a annoncé aujourd’hui le lancement d’un Laboratoire de services analytiques (Analytical Services Laboratory) à Hyderabad, en Inde. Le site spécialisé, conforme aux BPF, est géré par des systèmes LIMS (Laboratory Information Management Systems) agréés. Il respecte les plus hautes normes de qualité exigées par les organismes de réglementation et les clients pour le déve


HYDERABAD, India--(BUSINESS WIRE)--GVK Biosciences, una de las organizaciones de servicios del sector de las ciencias de la vida de Asia, ha anunciado el lanzamiento de un nuevo laboratorio de servicios analíticos en Hyderabad (India). La instalación especializada conforme a la norma GMP está gestionada por sistemas LIMS (Laboratory Information Management Systems) validados. Cumple con las más elevadas normas de calidad impuestas por los organismos normativos y clientes para el desarrollo y com


News Article | December 2, 2016
Site: www.businesswire.com

HYDERABAD, India--(BUSINESS WIRE)--GVK Biosciences, una delle maggiori organizzazioni asiatiche impegnate nell’offerta di servizi per il settore delle scienze naturali, ha annunciato oggi il lancio di un laboratorio di servizi analitici a Hyderabad, India. Il laboratorio specializzato a norma GMP è gestito dall’entità convalidata Laboratory Information Management Systems (LIMS). Esso è conforme ai massimi standard qualitativi sanciti dagli enti normativi competenti e dai clienti per lo sviluppo


News Article | December 2, 2016
Site: www.businesswire.com

HYDERABAD, India--(BUSINESS WIRE)--GVK Biosciences, een van de toonaangevende Aziatische dienstverleners voor de levenswetenschappen, heeft vandaag het Analytical Services Laboratory in Hyderabad in India gepresenteerd. Het gespecialiseerde GMP-conforme complex wordt beheerd met Laboratory Information Management Systems (LIMS). De faciliteit voldoet aan de hoogste kwaliteitseisen van toezichthouders en cliënten voor de ontwikkeling en marketing van medicijn. GVK BIO kan zijn cliënten nu helpen


Sen S.,GVK Biosciences | Potti V.R.,GVK Biosciences | Potti V.R.,Andhra University | Surakanti R.,GVK Biosciences | And 3 more authors.
Organic and Biomolecular Chemistry | Year: 2011

A highly efficient enantioselective SNAr reaction of chiral acyl bicyclic lactam with substituted-2,4-dinitrobenzenes was developed, affording products containing quarternary stereogenic centers. They are further utilized towards an enantioselective synthesis of spirooxoindoles. © 2011 The Royal Society of Chemistry.


Piatnitski Chekler E.L.,Pfizer | Khan T.A.,GVK Biosciences | Mamidala R.,GVK Biosciences | Anderson J.T.,Pfizer | And 3 more authors.
Tetrahedron Letters | Year: 2012

4-Substitued azaindolines, which are isosteres of indolines, are useful synthetic building blocks that reduce the risk of bioactivation induced idiosyncratic toxicity have been prepared. Multigram routes to 2,3-dihydro-1H-pyrrolo[2,3-c]pyridine-4-triflate 16, 2,3-dihydro-1H-pyrrolo[2,3- b]pyridine-4-carbonitrile 20 and 4-chloro-2,3-dihydro-1H-pyrrolo[2,3-d] pyridazine 30 are outlined. © 2011 Elsevier Ltd. All rights reserved.


News Article | December 1, 2016
Site: www.businesswire.com

HYDERABAD, India--(BUSINESS WIRE)--#API--GVK Biosciences, one of Asia’s leading life sciences service organizations today announced the launch of an Analytical Services Laboratory in Hyderabad, India.

Loading GVK Biosciences collaborators
Loading GVK Biosciences collaborators